UNSPSC 51453302: Thiram

This classification denotes a fungicide with the molecular formula C6H12N2S4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 0D771IS0FH, chemically known as thiuram disulfide, tetramethyl- but more generally known as thiram, which bears U.S. NIH Compound Identifier 5455. European Medicines Agency schedules Thiram in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10987MIG.

The term THIRAM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13 No. 1, 1999, List 41). World Health Organization schedules thiram in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. THIRAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51453302 Thiram is a Commodity code that does not align with the recent state and local procurement opportunities posted under it. The solicitations associated with this code — naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies, and generic pharmaceuticals and OTC products — involve health-care supplies, pharmaceutical sourcing, and emergency medical equipment rather than thiram, a fungicidal chemical used in agriculture and industrial applications. The mismatch suggests either a data-classification error in the state and local procurement system or that thiram procurement activity does not currently generate publicly visible solicitations among state and local buyers. State and local governments may source thiram indirectly through cooperative purchasing agreements or bundled agricultural procurement vehicles, but no active RFP, RFQ, IFB, or ITB notices specifically naming thiram appear in recent state or local purchasing records.

The geographic spread of opportunities posted under this code spans Florida, Texas, and Minnesota, though the work solicited bears no substantive relationship to the commodity code itself. Seminole County, Florida issued an IFB for naloxone and safe drug deactivation systems due July 26, 2023; the City of Tampa issued a sheltered-market IFB for medical and first aid supplies with a response deadline of March 13, 2026, carrying an estimated contract value of $700,000 and restricted to certified Small Local Business Enterprises; the Texas Health and Human Services Commission issued an RFI on direct-to-manufacturer pharmacy programs closing April 3, 2026; and the Minnesota Multistate Cooperative Purchasing Alliance issued an RFP for generic pharmaceuticals and OTC products due March 26, 2026. The code shows no identifiable recent activity relevant to thiram procurement among state, county, city, or special-purpose district buyers.